Log in to search using one of your social media accounts:

 

1st International Eurasian Mycology Congress
Date: Wednesday, May 24, 2017Year: 2017Location: Manisa Celal Bayar University, Anemon Hotel in Manisa, Turkey (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ERROR: ISHAM Newsletter
For those who received a copy of the ISHAM newsletter on or around 19th May 2017 (i.e. end of last week) ISHAM have discovered that one of the conferences featured is not one they wish  to associate with as members have highlighted that it falls below a standard they would expect.The conference in question is  The Annual Congress on Fungal Infections, Diseases& Treatment is planned November 16-17, 2017 in Atlanta, Georgia, U.S.A., organized by Pulsus Group Inc.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

eANOFEL Medical Mycology Educational Website Opens
The French College of Parasitologists and Medical Mycologists (ANOFEL) has launched an educational website called " eANOFEL " . Available in French/English and completely free after registration, this website is a database consisting of more than 1800 pictures and video clips covering all fields of Medical Mycology (and Parasitology). New pics/videos have just been added. Contact:  Florent Morio orDominique Chabasse.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ImResFun2017: Registration Now Open
Date: Wednesday, May 24, 2017Year: 2017Location: Innsbruck, Austria (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington. The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in pote...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news

Planning for the 20th ISHAM Congress is proceeding
The main traits of the program of 20th ISHAM Congress in Amsterdam are nearing completion and will soon appear on the website. Abstract submission will be possible from 1 August onwards. Note that there are several pre- and post-congress activities: workshops on dermatophytes, black yeasts and chromoblastomycosis, veterinary mycology, a course on histopathology, and more to come. If your organization wishes to have a meeting or otherwise, pleasecontact the organization.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ATS Roundup: Emulate models viral infection in “asthma-on-a-chip”
Emulate‘s small airway-lung chip could help researchers study viral-induced exacerbations of asthma, according to data presented this week at the American Thoracic Society’s annual meeting. The studies were conducted as part of the company’s partnership with (NYSE:MRK). The collaborative project was designed to enable development of new anti-inflammatory treatments for patients with asthma, according to Emulate. Get the full story at our sister site, Drug Delivery Business News.   The post ATS Roundup: Emulate models viral infection in “asthma-on-a-chip” appeared first on MassDevice....
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Emulate Inc Merck Source Type: news

eANOFEL images
The eANOFEL website is a library containing more than 1800 images (600 medical mycology (May 2017)) and some video clips covering all themes of Parasitology and Medical Mycology. This educational tool is dedicated both to teachers who wish to illustrate their presentations and students to complete their training effectively. It provides images on the morphology of parasites (including some in motion) and on major fungal species of medical interest, on their epidemiology and the diseases they cause. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Research fellows (early career research fellowship)
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Hookahs vs. Cigarette Smoking (Addiction and Health Dangers)
Title: Hookahs vs. Cigarette Smoking (Addiction and Health Dangers)Category: Diseases and ConditionsCreated: 5/24/2017 12:00:00 AMLast Editorial Review: 5/24/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 24, 2017 Category: Respiratory Medicine Source Type: news

Hookahs vs. Cigarettes (Addiction and Health Dangers)
Title: Hookahs vs. Cigarettes (Addiction and Health Dangers)Category: Diseases and ConditionsCreated: 5/24/2017 12:00:00 AMLast Editorial Review: 5/24/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 24, 2017 Category: Respiratory Medicine Source Type: news

Nearly 500 supporters joined ATS rally on Capitol Hill: Lab coats for lungs
(American Thoracic Society) In an ATS 2017 International Conference first, respiratory health professionals and patients joined other conference attendees at a rally near the Capitol on Tuesday, May 23 to voice their concerns about recent policies that threaten to undermine many of the ATS's advocacy priorities including: research funding, tobacco regulation, affordable health care, and clean air. Also participating in the rally was US senators Edward Markey (D-MA) and Tom Carper (D-DE). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2017 Category: International Medicine & Public Health Source Type: news

8 Habits That Make Millennials Stressed, Anxious And Unproductive
A version of this article was originally published on Forbes. Sign up for Caroline’s newsletter to get her writing sent straight to your inbox. According to the American Psychological Association (APA), millennials experience more stress and are less able to manage it than any other generation. More than half of us admit to having lain awake at night during the past month from stress. Not surprisingly, millennials are also more anxious than older Americans. The APA reports that 12 percent of millennials have a diagnosed anxiety disorder—almost twice the percentage of Boomers. On a non-clinical scale, a BD...
Source: Healthy Living - The Huffington Post - May 24, 2017 Category: Consumer Health News Source Type: news

ATS: Lower ARDS Mortality at High - Volume Intensive Care Units
Lower ICU mortality, hospital length of stay for acute respiratory distress syndrome at high - volume ICUs (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 24, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Critical Care, Nursing, Pulmonology, Conference News, Source Type: news

Treatment of COPD Exacerbations Varies by Respiratory Symptom (CME/CE)
(MedPage Today) -- Steroids much more likely for patients with dyspnea, researchers find (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 23, 2017 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 23, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Philips picks up airway clearance device dev RespirTech Royal Philips said today it inked a deal to acquire airway clearance solution developer RespirTech for an undisclosed amount. St. Paul, Minn.-based RespirTech was founded ...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Filtered Cigarettes May Up Rates of Lung Adenocarcinoma
Design of cigarette filters with ventilation implicated in rising rates (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pulmonology, Journal, Source Type: news

VitalConnect closes $33m Series C round
Wearable biometric diagnostic patch company VitalConnect said today it closed a $33 million Series C preferred stock financing round. The funding round was led by newly invested MVM Life Science Partners and Baxter Ventures, the San Jose, Calif.-based company said. As part of the round, MVM founder Dr. Stephen Reeders will join the company’s board of directors. “MVM has been looking for some time for a wireless technology that can deliver better care for patients and a high return on investment for providers, across a range of care environments. We have found it in VitalConnect,” MVM founde...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Vital Connect Source Type: news

ATS: Sleep Apnea, Insomnia in Blacks Often Go Undiagnosed
High prevalence of undiagnosed sleep disorders seen in study population (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Nursing, ENT, Pulmonology, Conference News, Source Type: news

ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news

Pot Use May Boost Respiratory Burden in Middle Age (CME/CE)
(MedPage Today) -- Exacerbation still a problem even without concurrent tobacco use (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2017 Category: Allergy & Immunology Source Type: news

Philips picks up airway clearance device dev RespirTech
Royal Philips (NYSE:PHG) said today it inked a deal to acquire airway clearance solution developer RespirTech for an undisclosed amount. St. Paul, Minn.-based RespirTech was founded in 2004 and has approximately 210 employees. The company produces airway clearance devices for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease and cystic fibrosis. Philips said that the addition of RespirTech’s portfolio will allow Philips to “accelerate its growth in respiratory care,” specifically for COPD patients with bronchiectasis. The acquired portfolio includes a clinica...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Respiratory royal-philips Source Type: news

Novartis ’ Ultibro Breezhaler tops corticosteroid for COPD in head-to-head study
Novartis (NYSE:NVS) said today that a new analysis of its head-to-head Flame trial showed that inhaled corticosteroids may not be necessary in some chronic obstructive pulmonary disease patients with high blood eosiophil counts. The data demonstrated that the company’s Ultibro Breezhaler provided better or similar benefits compared to Seretide, an inhaled corticosteroid, in COPD patients regardless of eosiophil count. These results contrast with previous work suggesting better outcomes with inhaled corticosteroids for patients with high eosinophil counts. Get the full story at our sister site, Drug Delivery Business ...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Novartis Source Type: news

Philips-Sponsored Clinical Study Demonstrates Significant Breakthrough for COPD Treatment
Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation. (Source: eHealth News EU)
Source: eHealth News EU - May 23, 2017 Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news

Could 'Safer' Filtered Cigarettes Be More Deadly?
Title: Could 'Safer' Filtered Cigarettes Be More Deadly?Category: Health NewsCreated: 5/22/2017 12:00:00 AMLast Editorial Review: 5/23/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 23, 2017 Category: Respiratory Medicine Source Type: news

ATS: First Abx Rx Doesn ’ t Work for ~ 25 % of Pneumonia Cases
One in four adult patients do not respond to initial prescription of antibiotic treatment (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Conference News, Source Type: news

Poverty Affects Severity of Organ Damage Due to Lupus
And, pregnancy complications higher among non - white patients with lupus (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Nephrology, Neurology, Nursing, Pathology, Pulmonology, Rheumatology, Journal, Source Type: news

FDA labels Philips Respironics V60 ventilator recall as Class I
The FDA today labeled a recall of Royal Philips (NYSE:PHG) Respironics‘ V60 ventilators as Class I. Class I recall designations, the agency’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The Respironics V60 non-invasive ventilator is designed to provide continuous or intermittent breathing support to pediatric patients weighing at least 44 lbs or adult patients, according to the recall notice. The company is recalling the device over issues with pins within the internal cable that conne...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Respiratory Respironics royal-philips Source Type: news

Holliston biotech faces possible delisting, but CEO remains confident
Biostage, a Holliston-based biotech developing organ implants to treat cancers in the respiratory tract, said Monday it faces a possible delisting from the Nasdaq. But its CEO, a former top official at Genzyme, remains confident that the company will avoid that fate. Biostage (Nasdaq: BSTG) said Monday it had received a letter from the exchange stating that it failed to meet two minimum requirements for listing: a $1 share price and $2.5 million in stockholders' equity. The 25-employee company said… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Holliston biotech faces possible delisting, but CEO remains confident
Biostage, a Holliston-based biotech developing organ implants to treat cancers in the respiratory tract, said Monday it faces a possible delisting from the Nasdaq. But its CEO, a former top official at Genzyme, remains confident that the company will avoid that fate. Biostage (Nasdaq: BSTG) said Monday it had received a letter from the exchange stating that it failed to meet two minimum requirements for listing: a $1 share price and $2.5 million in stockholders' equity. The 25-employee company said… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 22, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Triple-combo inhaler for COPD wins recommendation for approval in EU
Chiesi Group said today that the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended that the EMA approve its extra-fine triple combination inhaler for the treatment of chronic obstructive pulmonary disease. The Trimbow device combines an inhaled corticosteroid, a long-acting beta2-agonist and a long-acting muscarinic antagonist. The healthcare group said it is the 1st time the extra-fine triple therapy has been available in a single inhaler. Get the full story at our sister site, Drug Delivery Business News. The post Triple-combo inhaler for COPD wins recommendation for approval in...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat chiesigroup Source Type: news

Philips, ResMed tout collaborative home ventilation therapy COPD study results
This study shows that home non-invasive ventilation is a potent, therapeutic tool that clinicians can use to help keep patients with advanced COPD out of the hospital. We hope that this will, in turn, allow them to lead healthier and more active lives at home. These findings add considerably to our knowledge of this highly prevalent and debilitating respiratory disorder, and are expected to greatly influence how clinicians care for patients with COPD on long-term oxygen therapy,” Philips chief medical liaison Dr. Teofilo Lee-Chiong Jr. said in a press release. “This trial adds decisively to the growin...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory ResMed Inc. royal-philips Source Type: news

KIT Inhibition by Imatinib Helps Severe Refractory Asthma
Improvement in airway hyperresponsiveness seen with imatinib versus placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Nine of Ten Practices Surveyed Have Dismissed Patients
Reasons include inappropriate behavior toward staff, violation of Rx policies, repeatedly missed appointments (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Allergy, Nephrology, Neurology, Nursing, Ophthalmology, Orthopedics, ENT, Psychiatry, Pulmonology, Rheumatology, Urology, Anesthesiology Source Type: news

Patients Often Prescribed Futile Drugs in Last Months of Life
Researchers find many still prescribed long - term disease - preventing medications (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Nephrology, Neurology, Nursing, Oncology, Pharmacy, Pulmonology, AIDS, Anesthesiology & Pain, Journal, Source Type: news

Quvium ’s cough monitor boosts compliance by involving caregivers
When Steven Schmidt worked at Vertex Pharmaceuticals (NSDQ:VRTX), Eric Olson – the man who led the development of the 1st drug to treat the underlying causes of cystic fibrosis – asked Schmidt to look into ways that families could become more engaged with managing a patient’s condition. Olson pointed towards a publication that showed that involving caregivers added 8 years of life expectancy to children with cystic fibrosis. Schmidt, who now serves as founder and CEO of Quvium, took that idea and began development of a wearable cough monitor that alerts patients’ caregivers when a cough is out of th...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Patient Monitoring Pharmaceuticals Respiratory Wall Street Beat quvium Source Type: news

Intersurgical to Attend Euroanaesthesia
Intersurgical has announced it will be showcasing its full respiratory product range on stand 47 at Euroanaesthesia. (Source: Hospital Management)
Source: Hospital Management - May 22, 2017 Category: Hospital Management Source Type: news

First-Try Antibiotics Now Fail in 1 in 4 Adult Pneumonia Cases
Title: First-Try Antibiotics Now Fail in 1 in 4 Adult Pneumonia CasesCategory: Health NewsCreated: 5/21/2017 12:00:00 AMLast Editorial Review: 5/22/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 22, 2017 Category: Respiratory Medicine Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
Title: Could Cancer Drug Gleevec Help With Severe Asthma?Category: Health NewsCreated: 5/19/2017 12:00:00 AMLast Editorial Review: 5/22/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 22, 2017 Category: Respiratory Medicine Source Type: news

Graphene-based sensor could improve evaluation, diagnosis and treatment of asthma
(Rutgers University) Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2017 Category: International Medicine & Public Health Source Type: news

First - Try Antibiotics Now Fail in 1 in 4 Adult Pneumonia Cases
Patients typically helped by other means, but levels of drug resistance are concerning, researchers say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 21, 2017 Category: Respiratory Medicine Tags: Infections, Pulmonology, Geriatrics, News, Source Type: news

Ventilation Plus Home Oxygen Works After COPD Exacerbation (CME/CE)
(MedPage Today) -- Study looked at patients with persistent hypercapnia (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 21, 2017 Category: Respiratory Medicine Source Type: news

New hope for patients with severe lung disease
(NIHR Biomedical Research Centre at Guy ’ s and St Thomas ’ and King ’ s College London) Patients suffering from severe lung disease could see their lives transformed thanks to a 'game-changing' clinical trial carried out by UK experts and led by the team from the Lane Fox Respiratory Service based at Guy's and St Thomas' in London.The HOT-HMV trial (Home Oxygen Therapy-Home Mechanical Ventilation), which involved giving selected patients a breathing machine to be used in their home in addition to oxygen therapy, was found to reduce readmissions to hospital following an acute infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 21, 2017 Category: International Medicine & Public Health Source Type: news

Hemodialysis and the intubated salicylate-toxic patient
3.5 out of 5 stars The association of hemodialysis and survival in intubated salicylate-poisoned patients. McCabe DJ, Lu JJ. Am J Emerg Med 2017 Apr 10 [Epub ahead of print] Abstract [Disclosure: the co-authors of this paper are members of the Toxikon Consortium in Chicago, as am I.] This retrospective observational study looked at cases from the Illinois Poison Center over 12 years (2003 thru 2015) to identify intubated patients with recorded serum salicylate levels> 50 mg/dL. The goal was “to describe the impact of hemodialysis on survival rates of salicylate-intoxicated patients . . .”...
Source: The Poison Review - May 20, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical aspirin poisoning enhanced elimination hemodialysis salicylate toxicity Source Type: news

Demystifying Medicine 2017: Current Infectious Disease Challenges
National Institutes of Health. 05/16/2017 This one-hour, 25-minute presentation discusses infectious disease challenges in 2017: established infectious diseases, newly emerging diseases, and re-emerging diseases. It provides examples of established infectious diseases of global health importance, and global examples of newly emerging and re-emerging infectious diseases, including chikungunya, dengue, and Middle East respiratory syndrome coronavirus (MERS-CoV). It includes a detailed discussion of the Zika virus, yellow fever, Ebola, and pandemic influenza. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Dis...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 20, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
Small study suggests a new approach might one day help those with uncontrolled lung disease (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 19, 2017 Category: Respiratory Medicine Tags: Nursing, Oncology, Pharmacy, Pulmonology, Asthma, Research, News, Source Type: news

Red Meat Increases Risk of Dying From 8 Diseases
High red meat consumption increased the rate of dying from cancer, heart disease, respiratory disease, stroke, diabetes, infections, kidney disease and liver disease. (Source: NYT Health)
Source: NYT Health - May 19, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Meat Alzheimer's Disease Liver Heart Respiratory Diseases Diabetes Source Type: news

Researchers develop t-shirt embedded respiratory sensor, hopeful for future hospital applications
Researchers from the Université Laval in Canada have developed a novel respiration sensor built into a cotton t-shirt, with hopes that future versions could allow hospital patients to be comfortably monitored while free to be mobile. The sensor is composed of multi-material fibers arranged in the form of a spiral antenna, which monitors changes in antenna geometry due to chest expansion and the displacement of the air volume in the lungs, according to the developers. The device can also connect to short-range wireless communication devices, allowing for remote monitoring of respiration, according to a study publishe...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Patient Monitoring Research & Development Respiratory Source Type: news

Libya: Migrants and Refugees Suffering from Disease and Malnutrition in Detention Centers
Field newsLibya: Migrants and Refugees Suffering from Disease and Malnutrition in Detention CentersMay 19, 2017In Libya, Doctors Without Borders/M édecins Sans Frontières (MSF) continues to provide lifesaving and primary health care to refugees and migrants detained in the capital Tripoli.During the first quarter of 2017, more than 4,000 medical consultations took place in seven different detention centers nominally under the control of the Directorate for Combating Illegal Migration (DCIM). Around 1,300 people in detention were treated every month via mobile clinics for conditions including skin disease, dia...
Source: MSF News - May 19, 2017 Category: International Medicine & Public Health Authors: Elias Primoff Source Type: news